![]() |
FDA approves ABRAXANE chemotherapy drug for treatment of metastatic pancreatic cancer
The Pancreatic Cancer Action Network is pleased to announce that today ABRAXANE® was approved by the U.S. Food and Drug Administration (FDA) to treat metastatic pancreatic cancer.
More... |
| All times are GMT -7. The time now is 12:20 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021